| HOME >> BIOLOGY >> TECHNOLOGY |
ASSETS
Current assets 2008 2007
Cash and cash equivalents $ 64,310,448 $ 26,992,025
Accounts receivable 13,214,531 14,309,818
Other receivables 238,835 216,236
Inventories 408,358 203,054
Prepayment 1,806,605 176,094
Total current assets 79,978,777 41,897,227
Property, plant and equipment and
land use right 13,812,749 2,682,617
Total assets 93,791,526 44,579,844
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable 2,786,180 1,523,471
Tax payables 22,317,982 18,019,721
Other payables and accruals 1,792,156 1,126,645
Total current liabilities $ 26,896,318 $ 20,669,837
Non-current liabilities
Convertible Note, net of discount of
$8,554,365 as of March 31, 2008 16,445,635 --
Embedded derivatives 5,752,000 --
Interest payable 302,306 --
Total non-current liabilities $ 22,499,941 $ --
Commitments and contingencies
Stockholders' equity:
Common stock 1,708 1,708
Additional paid-in capital 7,863,031 7,863,031
Retained earnings 29,827,144 12,284,900
Accumulated other comprehensive
income 3,677,590 73
'/>"/>
| SOURCE China-Biotics, Inc. Copyright©2008 PR Newswire. All rights reserved |